Predicting Antibiotic Tolerance in hvKP and cKP Respiratory Infections Through Biofilm Formation Analysis and Its Resistance Implications

References

• Wahab S, Ahmad I, Irfan S, Siddiqua A, Usmani S, Ahmad MP. Pharmacological efficacy and safety of Glycyrrhiza glabra in the treatment of respiratory tract infections. Mini Reviews in Med Chem. 2022;22(11):1476–1494. doi:10.2174/1389557521666210927153001
   PubMed Web of Science ®Google Scholar
• Hobson CA, Pierrat G, Tenaillon O, et al. Klebsiella pneumoniae carbapenemase variants resistant to ceftazidime-avibactam: an evolutionary overview. Antimicrob Agents Chemother. 2022;66(9):e0044722. doi:10.1128/aac.00447-22
   PubMed Web of Science ®Google Scholar
• David S, Reuter S, Harris SR, et al. Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread. Nat Rev Microbiol. 2019;4(11):1919–1929. doi:10.1038/s41564-019-0492-8
   PubMed Web of Science ®Google Scholar
• Russo TA, MacDonald U. The galleria mellonella infection model does not accurately differentiate between hypervirulent and classical Klebsiella pneumoniae. mSphere. 2020;5(1). doi:10.1128/mSphere.00850-19
   PubMed Web of Science ®Google Scholar
• Liu C, Du P, Xiao N, Ji F, Russo TA, Guo J. Hypervirulent Klebsiella pneumoniae is emerging as an increasingly prevalent K. pneumoniae pathotype responsible for nosocomial and healthcare-associated infections in Beijing, China. Virulence. 2020;11(1):1215–1224. doi:10.1080/21505594.2020.1809322
   PubMed Web of Science ®Google Scholar
• Wang Y, Hua M, Wang J, et al. Clonal dissemination of multidrug-resistant and hypervirulent Klebsiella pneumoniae clonal complex in a Chinese hospital. Pathogens. 2022;11(10):1202. doi:10.3390/pathogens11101202
   PubMed Web of Science ®Google Scholar
• Walker KA, Miller VL. The intersection of capsule gene expression, hypermucoviscosity and hypervirulence in Klebsiella pneumoniae. Curr Opin Microbiol. 2020;54:95–102. doi:10.1016/j.mib.2020.01.006
   PubMed Web of Science ®Google Scholar
• Nobrega DB, Calarga AP, Nascimento LC, et al. Molecular characterization of antimicrobial resistance in Klebsiella pneumoniae isolated from Brazilian dairy herds. J Dairy Sci. 2021;104(6):7210–7224. doi:10.3168/jds.2020-19569
   PubMed Web of Science ®Google Scholar
• Tang M, Kong X, Hao J, Liu J. Epidemiological characteristics and formation mechanisms of multidrug-resistant hypervirulent Klebsiella pneumoniae. Front Microbiol. 2020;11:581543. doi:10.3389/fmicb.2020.581543
   PubMed Web of Science ®Google Scholar
• Bassetti M, Righi E, Carnelutti A, Graziano E, Russo A. Multidrug-resistant Klebsiella pneumoniae: challenges for treatment, prevention and infection control. Exp Rev Anti-Infective Ther. 2018;16(10):749–761. doi:10.1080/14787210.2018.1522249
   PubMed Web of Science ®Google Scholar
• Li L, Yu T, Ma Y, et al. The genetic structures of an Extensively Drug Resistant (XDR) Klebsiella pneumoniae and its plasmids. Front Cell Infect Microbiol. 2018;8:446. doi:10.3389/fcimb.2018.00446
   PubMed Web of Science ®Google Scholar
• Kidd TJ, Mills G, Sá-Pessoa J, et al. A Klebsiella pneumoniae antibiotic resistance mechanism that subdues host defences and promotes virulence. EMBO Mol Med. 2017;9(4):430–447. doi:10.15252/emmm.201607336
   PubMed Web of Science ®Google Scholar
• Sawa T, Kooguchi K, Moriyama K. Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistance. J Intensive Care. 2020;8(1):13. doi:10.1186/s40560-020-0429-6
   PubMed Web of Science ®Google Scholar
• Bonomo RA. β-lactamases: a focus on current challenges. Cold Spring Harb Perspect Med. 2017;7(1):a025239. doi:10.1101/cshperspect.a025239
   PubMed Web of Science ®Google Scholar
• Frère JM, Sauvage E, Kerff F. From ”an enzyme able to destroy penicillin” to carbapenemases: 70 years of beta-lactamase misbehaviour. Curr Drug Targets. 2016;17(9):974–982. doi:10.2174/1389450116666151001112859
   PubMed Web of Science ®Google Scholar
• Kil K-S, Darouiche RO, Hull RA, Mansouri MD, Musher DM. Identification of a Klebsiella pneumoniae strain associated with nosocomial urinary tract infection. J Clin Microbiol. 1997;35(9):2370–2374. doi:10.1128/jcm.35.9.2370-2374.1997
   PubMed Web of Science ®Google Scholar
• Humphries R, Bobenchik AM, Hindler JA, Schuetz AN. Overview of changes to the clinical and laboratory standards institute performance standards for antimicrobial susceptibility testing, M100. J Clin Microbiol. 2021;59(12). doi:10.1128/JCM.00213-21
   Web of Science ®Google Scholar
• Russo TA, MacDonald U, Hassan S, et al. An assessment of siderophore production, mucoviscosity, and mouse infection models for defining the virulence spectrum of hypervirulent Klebsiella pneumoniae. Msphere. 2021;6(2). doi:10.1128/mSphere.00045-21.
   Web of Science ®Google Scholar
• Relucenti M, Familiari G, Donfrancesco O, et al. Microscopy methods for biofilm imaging: focus on SEM and VP-SEM pros and cons. Biology. 2021;10(1):51. doi:10.3390/biology10010051
   PubMedGoogle Scholar
• Wei T, Zou C, Qin J, et al. Emergence of hypervirulent ST11-K64 Klebsiella pneumoniae poses a serious clinical threat in older patients. Front Public Health. 2022;10:765624. doi:10.3389/fpubh.2022.765624
   PubMed Web of Science ®Google Scholar
• Kaushik V, Tiwari M, Tiwari V. Interaction of RecA mediated SOS response with bacterial persistence, biofilm formation, and host response. Int J Biol Macromol. 2022;217:931–943. doi:10.1016/j.ijbiomac.2022.07.176
   PubMed Web of Science ®Google Scholar
• Shui J, Luo L, Xiang YG, Shi GM, Wu JL, Pan JH. 高毒力肺炎克雷伯菌生物被膜形成能力及耐药性分析 [Analysis of biofilm-forming ability and drug resistance for Hypervirulent Klebsiella pneumoniae]. Zhonghua yu fang yi xue za zhi. 2023;57(9):1452–1457. Chinese. doi:10.3760/cma.j.cn112150-20220929-00938
   PubMedGoogle Scholar